C3.Ai, Inc. SEC Filings

Insider equity grant to a director with attendance‑based vesting. A Form 4 shows Director Richard C. Levin received a stock option to purchase 28,628 shares of Class A common stock exercisable at $19.16. The option grant date is 10/03/2025 with an expiration on 10/02/2035 and the option appears fully reported as a direct holding of 28,628 shares after the acquisition. Vesting begins on the Vesting Commencement Date (10/03/2025) and 12.5% of the shares vest on the last day of each fiscal quarter only if the director attends the regularly scheduled board meeting for that quarter; missed meetings suspend quarterly vesting and those suspended shares vest only if attendance requirements are later satisfied after the two‑year anniversary.

C3.ai director and EVP & Chief Commercial Officer Robert David Schilling received 470,420 fully vested Restricted Stock Units (RSUs) that convert one-for-one into Class A common shares. To cover tax withholding on those vested RSUs, the issuer automatically withheld and sold 240,121 shares at a weighted-average price of $17.2899. Separately, 230,299 shares were sold under a previously established Rule 10b5-1 trading plan dated June 23, 2025, also reported at a weighted-average price of $17.2899. Following the reported transactions, the filing shows beneficial ownership levels of 1,481,747, 1,241,626, and 1,011,327 shares on the separate reported lines respectively.

C3.ai, Inc. (AI) filed a Form 144/A notifying a proposed sale of 470,420 shares of common stock to be executed on or about 10/01/2025 on the NYSE through Merrill Lynch, 520 Newport Center Drive, Newport Beach, CA. The filing lists an aggregate market value of $8,133,514.76 for the shares and indicates 134,349,704 shares outstanding. The securities were acquired on 10/01/2025 as a stock bonus from C3 AI Inc., with payment and acquisition dates shown as the same date. No sales by the reporting person in the prior three months are reported. The filer affirms they are unaware of any undisclosed material adverse information about the issuer.

C3.ai, Inc. (AI) filed a Form 144 giving notice of a proposed sale of 470,420 shares of common stock through Merrill Lynch at an aggregate market value of $8,133,514.76. The filing shows 134,349,704 shares outstanding and lists the approximate date of sale as 10/01/2025. The securities were acquired as a stock bonus from C3 AI Inc. on 10/01/2025, with payment and consideration marked as N/A. The filer certifies they are unaware of undisclosed material adverse information about the issuer as part of the Form 144 signature representations.

C3.ai, Inc. announced that on September 14, 2025 its Board unanimously adopted the C3.ai, Inc. 2025 Inducement Plan, authorizing equity-based inducement awards to recruit and retain new employees. The plan reserves 5,000,000 shares of Class A common stock for non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. Grants under the plan are limited to new hires who meet NYSE "employment inducement" standards and require approval by independent directors or a wholly independent Compensation Committee. The plan was adopted without stockholder approval pursuant to NYSE rules and is incorporated by reference to the Form S-8 Exhibit 99.1.

Stephen Bradley Ehikian, Chief Executive Officer of C3.ai (AI), received equity awards on 09/15/2025 consisting of 1,140,902 RSUs and a stock option for 1,282,139 shares with a $17.53 exercise price. The RSUs convert to one share each on settlement; 399,316 RSUs vest on December 30, 2025 and the remainder vest in 11 equal quarterly installments thereafter provided continued service. The option vests 5% on December 15, 2025 and 5% quarterly thereafter and expires on September 14, 2035. The reported beneficial ownership figures after the transactions are 1,140,902 shares for RSUs and 1,282,139 underlying shares for the option. The Form 4 was signed by an attorney-in-fact on 09/17/2025.

C3.ai CFO Hitesh Lath reported multiple equity award settlements and an automated sell-to-cover tax withholding. On 09/15/2025 the reporting person had 8,007, 1,000 and 80,000 restricted stock units (RSUs) converted to Class A common stock and/or otherwise recorded as acquired, and also purchased 810 shares through the employee stock purchase plan on 09/15/2025. On 09/16/2025 the issuer automatically withheld and sold 46,881 shares to satisfy tax-withholding obligations at a weighted-average price of $16.99 per share (sales ranged $16.92–$17.12). Following the reported transactions the reporting person beneficially owned 209,154 shares of Class A common stock.

Thomas M. Siebel, reporting as Executive Chairman, disclosed the sale of 566,125 shares of C3.ai, Inc. (AI) on 09/16/2025 under a previously established Rule 10b5-1 trading plan dated 09/20/2024. The weighted-average price for the shares sold was $17.23, with individual sale prices ranging from $16.93 to $17.58. After the reported sale, the filing shows Mr. Siebel beneficially owns 2,510,102 shares of Class A common stock indirectly through trusts and investment entities and additional smaller indirect holdings totaling 1,489,320 shares across other entities.

The filing was signed by an attorney-in-fact on 09/17/2025. The disclosure identifies the ownership vehicles: The Siebel Living Trust, First Virtual Holdings, Siebel Asset Management entities, and The Siebel 2011 Irrevocable Children's Trust.

C3.ai, Inc. Form 144 filing (ticker: AI) reports a proposed sale of 46,881 common shares through Merrill Lynch on the NYSE with an aggregate market value of $796,292.03. The filing lists 134,349,704 shares outstanding for the issuer and an approximate sale date of 09/16/2025. The securities to be sold were recorded as acquired on 09/15/2025 through a restricted stock unit vest event totaling 89,007 shares, with payment noted on 09/16/2025. The filing also discloses prior sales by the same person: 17,689 common shares sold on 06/27/2025 with gross proceeds of $441,558.46. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.